Billable / Specific Code
ICD-10-CM E34.322 is the diagnosis code for Insulin-like growth factor-1 (IGF-1) resistance. This code falls under the section "Disorders of other endocrine glands" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where E34.322 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E34.322 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E34.322 is the ICD-10-CM diagnosis code for "Insulin-like growth factor-1 (IGF-1) resistance". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E34.322 is E34.32 ("Genetic causes of short stature"). E34.322 provides a more specific classification within this category.
E34.322 is located in Section E20-E35 — "Disorders of other endocrine glands" within Chapter 4 of the ICD-10-CM Tabular List.
Use E34.322 when the patients documented diagnosis matches "Insulin-like growth factor-1 (IGF-1) resistance" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Insulin-like growth factor-1 (IGF-1) resistance is E34.322.
Yes, E34.322 can be used as a primary diagnosis code since it is billable and specific.
E34.322 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E34.322 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.